FibroBiologics closes $3M public offering of common stock and warrants at $1.32/unit

FibroBiologics, Inc.

• Offering of 2,272,728 shares (or pre-funded warrants) plus warrants, combined price $1.32/unit; net proceeds ~$2.5M after fees.
• Warrants exercise price $1.32, exercisable only after stockholder approval; if fully cash-exercised, additional $3M proceeds possible.
• Pre-funded warrants exercise price $0.00001, no expiration; beneficial ownership cap 9.99%.
• Placement agent H.C. Wainwright received 7.0% cash fee, 1.0% management fee, and 159,091 placement agent warrants at $1.65.
• Lock-up: insiders 30 days; company restricted from further equity issuance for 30 days and no variable-rate transactions for one year.